Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies흡연이 COVID-19 백신에 대한 면역학적 반응에 영향을 미칩니까? VASCO 연구의 증거 및 추가 연구의 필요성Article Published on 2022-02-012022-09-12 Journal: Public health [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] Administered age Analysis antibodies Antibody titre BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine BNT162b2 vaccine conducted COVID-19 COVID-19 vaccine decrease dose faster HCW HCWs healthcare worker humoral identify IgG Immunoglobulin Immunological response infection with SARS-CoV-2 interquartile range IQR Italian median Non-COVID-19 participant question remained required Research SARS-CoV-2 serological serology test Sex significant difference smoker smoking smoking status titre undergo vaccination Vaccine vaccine response [DOI] 10.1016/j.puhe.2021.12.013 PMC 바로가기 [Article Type] Article
Seroprevalence and risk factors for SARS-CoV-2 among incarcerated adult men in Quebec, Canada (2021)캐나다 퀘벡에 수감된 성인 남성 중 SARS-CoV-2에 대한 혈청 유병률 및 위험 요소(2021)Major Article Published on 2022-01-172022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, [키워드] 95% CI 95% confidence interval 95%CI adjusted antibody association calculated Characteristics conducted cross-sectional employment examined Factor incarcerated incarceration increased risk individual Infection prevention male measure Measures men outbreak participant Poisson regression model positive prevalence ratio Primary outcome prison Quebec, Canada questionnaire recruited representing Result risk factor robust Roche SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection serology test Seropositivity Seroprevalence Sociodemographic tested vaccination variable [DOI] 10.1093/cid/ciac031 PMC 바로가기 [Article Type] Major Article
Association of Self-reported COVID-19 Infection and SARS-CoV-2 Serology Test Results With Persistent Physical Symptoms Among French Adults During the COVID-19 PandemicArticle Published on 2022-01-012022-11-16 Journal: JAMA Internal Medicine [Category] 치료기술, [키워드] 95% CI age Analysis Anosmia anti-SARS-CoV-2 antibodies association belief breathlessness cause Cohort Complete COVID-19 COVID-19 infection COVID-19 pandemic cross-sectional analysis depressive symptom detect disease enzyme-linked immunosorbent fatigue French General population Health impair impairment individual infected with SARS-CoV-2 Infection initial laboratory-confirmed mechanism Odds ratio outcome participant Patient persistent Physical symptom physical symptoms positive Prevent problem promote Quality of life Regression reported Research Result SARS-CoV-2 serology test Sex significant interaction Symptom Test the SARS-CoV-2 virus these symptom Volunteer was used were excluded women [DOI] 10.1001/jamainternmed.2021.6454 PMC 바로가기
Performance of the T-SPOT Ⓡ.COVID test for detecting SARS-CoV-2-responsive T cellsSARS-CoV-2 반응성 T 세포 검출을 위한 T-SPOT Ⓡ.COVID 검사 성능Article Published on 2021-12-012022-09-11 Journal: International Journal of Infectious Diseases [Category] SARS, 진단, 치료기술, 치료법, [키워드] Activation Adaptive immune response anti-N IgG Blood common cold common cold coronavirus control group coronavirus COVID-19 cross-reactive detect Diagnosis ELISPOT evaluate IGRA Immunoglobulin Infection interferon interferon-gamma release assay less methodology NAAT nucleic acid nucleic acid amplification nucleic acid amplification test nucleocapsid participant Participants participants with SARS-CoV-2 Patient peptides performance performed reactive response SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike serology serology test seropositive T cell T cell response T cell responses T cells T-cell T-cells T-SPOT.COVID [DOI] 10.1016/j.ijid.2021.09.073 PMC 바로가기 [Article Type] Article
CAN IgG ANTIBODIES DIRECTED AGAINST DIFFERENT TARGETS SOLVE THE PROBLEM OF FALSE-POSITIVE RESULTS IN SARS-CoV-2 SEROLOGY?다른 표적에 대한 IgG 항체가 SARS-CoV-2 혈청학에서 위양성 결과의 문제를 해결할 수 있습니까?Article Published on 2021-12-012022-09-12 Journal: Acta clinica Croatica [Category] SARS, 진단, [키워드] addition Anti- SARS-CoV-2 IgG antigens cross-reactivity ELFA ELISA False-positive results France global pandemic IgG Infection Italy medium observation offer other coronavirus Patient positive Positive predictive value positive result RT-PCR assays SARS-CoV SARS-CoV 2 SARS-CoV-2 SARS-COV-2 infection serologic test serologic tests serology serology test serology testing Spread tested [DOI] 10.20471/acc.2021.60.04.25 PMC 바로가기 [Article Type] Article
SARS-CoV-2 seroprevalence in Mongolia: Results from a national population surveyResearch Paper Published on 2021-11-232022-10-30 Journal: The Lancet Regional Health - Western Pacific [Category] COVID-19, [키워드] Abstract acute respiratory syndrome age Appendix blood sample community transmission conducted coronavirus COVID-19 enrolled Factor finding Fisher funding Health identify Immunity Local measure Ministry of Health Mongolia Mongolian MONITOR National occurred pandemic Pandemics participant Population positive public health measures Quantitative Randomly research and development response Result SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 IgG antibody SARS-CoV-2 seroprevalence screened selected seroepidemiological studies serology test Seroprevalence seroprevalence survey Serosurvey Sex solidarity Spread Stratification subject Traditional translation Transmission vaccination variable WHO World Health Organisation [DOI] 10.1016/j.lanwpc.2021.100317 PMC 바로가기 [Article Type] Research Paper
A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trialSARS-COV-2 감염 (COVID-RED)의 원격 조기 발견을위한 일일 증상 일기 외에 웨어러블 장치의 효과를 조사하기위한 전향 적, 무작위, 단일 맹장, 크로스 오버 시험 : 연구의 구조적 요약.무작위 제어 시험을위한 프로토콜Update Published on 2021-10-112022-09-01 Journal: Trials [Category] MERS, SARS, 임상, 진단, 치료기술, 치료제, [키워드] 1:1 addition adhere Algorithm Algorithms all subject all subjects among others analysed antibody Antibody testing antibody tests Antigen antigen tests approach asked assigned Asymptomatic asymptomatic individual asymptomatic infection average baseline blinded Blinding can not capillary blood Chain Reaction changes in Characteristics cholinergic urticaria Cohort collected Complete conditions conducted consent form contribute control condition COVID-19 COVID-19 infection COVID-19 vaccination current Daily defined demographics described detect detection determine develop deviation diary dissemination Early detection element eligibility criteria eligible End enrolled enrolment evaluate exclusion exploratory feedback Follow-up followed by gold gold standard Health health resource heart rate incidence rates Inclusion inclusion criteria individual individuals infected individual infected individuals infected with SARS-CoV-2 Infection information Informed consent informed consent form initial involved Laboratory laboratory-confirmed SARS-CoV-2 infection machine learning management maximum media medical history Mobile application must nasal swab National natural infection Negative predictive value Netherland Netherlands notification NPV number objective occur outcome pacemaker parameter participant PCR PCR test PCR tests physiological physiological parameters polymerase chain polymerase chain reaction populations portal positive Positive predictive value PPV pre-symptomatic Predictive value primary analysis profession proportion Prospective protocol provided public health Pulse rate questionnaire randomization randomization sequence Randomized Randomized controlled trial Randomly receive recommendation recruited recruitment reduce remote reported resident resource responsible resulting risk RIVM Sample size SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 test SARS-CoV-2 virus sensitivity sequence sequence 1 Sequence 2 sequences serology serology test serology tests significantly skin temperature Smartphone social media specificity staff stratified stratified block randomization study participation Study protocol subject suffering supplementary material Symptom Symptom diary Symptoms target temperature test result tested the SARS-CoV-2 thought Transmission transmissions Trial Trial registration undergo urticaria used to evaluate vaccinated against COVID-19 vaccination Vaccine Variability wearable device website Well-being [DOI] 10.1186/s13063-021-05643-5 PMC 바로가기 [Article Type] Update
COVID-19 Testing and Diagnostics: A Review of Commercialized Technologies for Cost, Convenience and Quality of TestsCOVID-19 테스트 및 진단: 테스트의 비용, 편의성 및 품질에 대한 상용화 기술 검토Review Published on 2021-10-012022-09-10 Journal: Sensors (Basel, Switzerland) [Category] MERS, SARS, 변종, 진단, 치료기술, [키워드] antibody tests at home test attributes convenience COVID-19 COVID-19 diagnostic test COVID-19 infections COVID-19 patients COVID-19 testing detect diagnose diagnostics distribution Emergency use authorization faster FDA FDA authorized test kit feasibility healthcare in vitro management Mass testing Molecular tests platform priority profiles protocols Quality rapid antigen test Rapid antigen tests review SARS-CoV-2 SARS-CoV-2 detection screening programs serology serology test specimen specimen collection Supply chain surveillance testing technology Test Testing Transmission dynamics universal access variants [DOI] 10.3390/s21196581 PMC 바로가기 [Article Type] Review
Design of the Healthcare Worker Exposure Response and Outcomes (HERO) research platformRandomized Controlled Trial Published on 2021-10-012022-10-05 Journal: Contemporary clinical trials [Category] SARS, 임상, [키워드] 1:1 adverse events approach assessments Baseline assessment Blood caused clinical study clinical trial Community condition COVID-19 Day death double-blind Efficacy eligibility engage evaluate Evidence example exposure Follow-up HCQ HCW HCWs healthcare worker Healthcare workers Hydroxychloroquine Infection multicenter nasopharyngeal offer Pandemics participant PCR Placebo platform Pragmatic pragmatic trial Prophylaxis Quality of life Randomized receive registry repeated Research response resulting SARS CoV-2 Secondary objective serology test Study platform. Support symptoms of COVID-19 therapy Tolerability Treatment Trial viral shedding virus was done Weekly worker [DOI] 10.1016/j.cct.2021.106525 PMC 바로가기 [Article Type] Randomized Controlled Trial
Effectiveness and safety of ivermectin in the treatment of COVID-19: protocol for a systematic review and meta-analysisCovid-19의 치료에서 Ivermectin의 효과 및 안전성 : 체계적인 검토 및 메타 분석을위한 프로토콜Article Published on 2021-09-172022-08-31 Journal: BMJ Open [Category] meta-analysis, SARS, 임상, [키워드] acute respiratory syndrome Admission antiviral properties antiviral property approval assessment Bia bias risk carried clinical clinical pharmacology clinical trial clinical trials Clinical use COVID-19 criteria database development Diagnosis drug Effectiveness eligibility Ethical approval Ethics Evidence extracorporeal membrane oxygenation for inclusion Frequency GRADE hospitalisation in some incidence include Infection Infectious diseases intensive care intensive care unit Invasive mechanical ventilation involved item Ivermectin mean difference Meta-analysis methodology Mortality observational studies observational study outcome outcomes Patient patients with COVID-19 PCR-negative peer-reviewed Placebo Prophylactic PROSPERO protocol public health random-effects model randomised clinical trial Randomised clinical trials Real-time PCR registration number registry Relative risk Reporting required respiratory review risk serology test Severe acute respiratory syndrome Side effects subgroup analysis Support Symptom symptom resolution Symptomatic treatment systematic review systematic reviews the mean Treatment Trial Viral Viral load [DOI] 10.1136/bmjopen-2021-050532 PMC 바로가기 [Article Type] Article